Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 116

Sort by

Sort Order Select

Journal Articles

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Michelle A. Roesler, BS, Amy Linabery, PhD MS, Michaela Richardson, MPH, Adina Cioc, MD, Betsy A Hirsch, PhD, Phuong L. Nguyen, MD, Erica D. Warlick, MD, Jenny Poynter, PhD

Blood (2019) 134 (Supplement_1): 3014.

https://doi.org/10.1182/blood-2019-130940

Published: 2019

Journal Articles

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Santosh L. Saraf, MD, Vimal K. Derebail, MD, Xu Zhang, PhD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2268.

https://doi.org/10.1182/blood-2019-124737

Published: 2019

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Characteristics and Outcomes of Ibrutinib-Associated Musculoskeletal Toxicities in CLL Patients

Joanna Rhodes, MD, Anthony R. Mato, MD MSCE, Nicole Winchell, Kaitlin Kennard, RN, BSN, James Nathan Gerson, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD

Blood (2018) 132 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2018-99-115377

Published: 2018

Journal Articles

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Camila Albo, Sanjiv Kumar, PhD, Michael Pope, Bachelors/MDcal Student, Kyle Michael Kidwell, Bachelors/MDcal Student, Niren Patel, MBBS, Leigh Wells, MSN, Latanya Bowman, RN, Nadine Barrett, MSN, Xu Hongyan, PhD, Abdullah Kutlar, MD

Blood (2018) 132 (Supplement 1): 857.

https://doi.org/10.1182/blood-2018-99-115084

Published: 2018

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding

Deepa Jayakody Arachchillage, MD MRCP, FRCPath, Sharon Alavian, Jessica Griffin, MRCP, Kamala Gurung, MRCP, Richard Syzdlo, PhD, Nilanthi Karawitage, Michael Laffan, DM, FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2535.

https://doi.org/10.1182/blood-2018-99-116432

Published: 2018

Journal Articles

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Nadirah El-Amin, MPH, DO, Paul Nietert, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2018-99-117206

Published: 2018

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Brian Pennarola, MD, Patrick Demartino, MD, Dale W. Steele, MD, Susan J. Duffy, MD

Blood (2018) 132 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2018-99-117703

Published: 2018

Journal Articles

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Mahek Garg, Karina Raimundo, Anisha Patel, Richard H Ko

Blood (2018) 132 (Supplement 1): 2234.

https://doi.org/10.1182/blood-2018-99-116989

Published: 2018

Journal Articles

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Sara R. Vazquez

Blood (2018) 132 (21): 2230–2239.

https://doi.org/10.1182/blood-2018-06-848747

Published: 2018

Journal Articles

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Marie Piel-Julian, Matthieu Mahévas, Johanne Germain, Laetitia Languille, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Prudhomme, Laurent Sailler, Maryse Lapeyre-Mestre, Nicolas Limal, Odile Beyne-Rauzy, Marc Michel, Daniel Adoue, Bertrand Godeau, Guillaume Moulis, MD

Blood (2017) 130 (Supplement 1): 1041.

https://doi.org/10.1182/blood.V130.Suppl_1.1041.1041

Published: 2017

Journal Articles

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Lene Sofie Granfeldt Østgård, MD PhD, Mette Nørgaard, MD PhD, Lars Pedersen, MSc, PhD, René Østgård, MD PhD, Marianne Tang Severinsen, MD PhD, Claudia Schöllkopf, MD PhD, Claus Werenberg Marcher, MD PhD, Lone Smidstrup Friis, MD PhD, Morten Krogh Jensen, MD Dr.Sc.

Blood (2017) 130 (Supplement 1): 1305.

https://doi.org/10.1182/blood.V130.Suppl_1.1305.1305

Published: 2017

Journal Articles

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism

Scott D. Berkowitz, MD, Jeffrey I Weitz, MD FRCPC, FACP, Stephan Schmidt, Keith A A Fox, MBBS, Dirk Garmann, Dagmar Kubitza, Wolfgang Mueck, Gary Peters, MD, Isabel Reinecke, Alexander Solms, Theodore E Spiro, MD, Xiaoyu Yan, PhD MSc, Liping Zhang, Stefan Willmann

Blood (2017) 130 (Supplement 1): 1104.

https://doi.org/10.1182/blood.V130.Suppl_1.1104.1104

Published: 2017

Journal Articles

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

Blood (2017) 130 (Supplement 1): 2359.

https://doi.org/10.1182/blood.V130.Suppl_1.2359.2359

Published: 2017

Journal Articles

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

Jian-Qing Mi, MD PhD, Xiaohu (Frank) Fan, PhD, Jie Xu, PhDMD, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Shuangshuang Yang, Wu Zhang, PhD, Bing Chen, MD PhD, Yueying Wang, PhD, Xiangqin Weng, Junmin Li, Weijun Fu, MD, Hua Jiang, MD, Li Zhu, Zhu Chen, PhD, Sai-Juan Chen, PhD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 3115.

https://doi.org/10.1182/blood.V130.Suppl_1.3115.3115

Published: 2017

Journal Articles

Poor Responsiveness to Low-Dose Aspirin Contributes to Persistent In Vivo Platelet Activation in Polycythemia Vera

Paola Ranalli, MD, Giovanna Petrucci, PhD, Alfredo Dragani, MD, Mauro Di Ianni, MD PhD, Paolo Di Bartolomeo, MD, Viviana Cavalca, BSc, Benedetta Porro, PhD, Elena Tremoli, PhD, Carlo Patrono, MD, Bianca Rocca, MD

Blood (2017) 130 (Supplement 1): 2379.

https://doi.org/10.1182/blood.V130.Suppl_1.2379.2379

Published: 2017

Journal Articles

Impact of Treatment Cessation on Overall Disease Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Attempting Treatment-Free Remission (TFR): Findings from Enestfreedom and Enestop

Giuseppe Saglio, MD PhD, Timothy P. Hughes, MD, Andreas Hochhaus, MD, Dong-Wook Kim, MD PhD, Francis J. Giles, MD MB, FRCPath, Jerald P. Radich, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Prashanth Gopalakrishna, MD, Weiping Deng, Rafik Fellague-Chebra, MD, Sandip Acharya, MSc, Francois-Xavier Mahon, MD PhD

Blood (2017) 130 (Supplement 1): 1598.

https://doi.org/10.1182/blood.V130.Suppl_1.1598.1598

Published: 2017

Journal Articles

Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma

Kentaro Narita, MD, Hiroki Kobayashi, MD, Yoshiaki Abe, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2017) 130 (Supplement 1): 4132.

https://doi.org/10.1182/blood.V130.Suppl_1.4132.4132

Published: 2017

NARROW

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Characteristics and Outcomes of Ibrutinib-Associated Musculoskeletal Toxicities in CLL Patients

Characteristics and Potential Biomarkers of Adult Sickle Cell Patients with Chronic Pain

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells

Poor Responsiveness to Low-Dose Aspirin Contributes to Persistent In Vivo Platelet Activation in Polycythemia Vera

Impact of Treatment Cessation on Overall Disease Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Attempting Treatment-Free Remission (TFR): Findings from Enestfreedom and Enestop

Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only